Century Therapeutics, Inc.

IPSC ·Healthcare, Drug Manufacturers - General, United States
Financial Statements › Balance Sheet
Annual Quarterly

Balance Sheet

Line Item Jun 2026 Mar 2026 Dec 2025 Sep 2025 Jun 2025 Mar 2025 Dec 2024 Sep 2024
Assets
Cash & Equivalents $49.6M $51.0M $61.9M $55.5M $56.9M $51.9M $58.4M $52.6M
Accounts Receivable — — — — — — — —
Inventory — — — — — — — —
Total Current Assets $124.8M $139.0M $120.8M $137.7M $160.2M $169.6M $194.1M $206.0M
Property, Plant & Equipment $34.5M $47.6M $50.0M $53.7M $56.6M $59.5M $62.1M $65.3M
Goodwill — — — — — — — $4.7M
Intangible Assets (Excl. Goodwill) $34.2M $34.2M $34.2M $34.2M $34.2M $34.2M $34.2M $33.8M
Total Assets $287.0M $326.6M $223.7M $244.7M $284.7M $315.6M $353.2M $388.6M
Liabilities
Accounts Payable $4.8M $3.2M $4.8M $2.6M $3.2M $3.6M $3.1M $2.6M
Total Current Liabilities $15.1M $13.6M $20.2M $22.0M $14.9M $14.5M $129.8M $19.8M
Long-Term Debt — — — — — — — —
Total Liabilities $54.7M $61.8M $64.8M $68.4M $74.8M $75.2M $191.9M $192.9M
Stockholders' Equity
Retained Earnings $-848.1M $-813.6M $-791.9M $-772.7M $-738.3M $-705.8M $-782.3M $-746.3M
Total Stockholders' Equity $232.3M $264.7M $158.9M $176.3M $209.9M $240.4M $161.4M $195.7M
← Newer Page 1 of 3 Older →